|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print December 10, 2001
Division of Clinical Immunology, Institute of Medical Science,, University of Tokyo, Minato-ku, Tokyo 108-8639
Corresponding Author: hirotnk{at}ims.u-tokyo.ac.jp
Ligand-receptor coupling is one of the important constituents of signal transduction and essential for physiological transmission of actions of endogenous substances including steroid hormones. However, molecular mechanisms of the redundancy between glucocorticoid and mineralocorticoid remains unknown because of complicated cross-talk among, for example, these adrenal steroids, their cognate receptors, and target genes. Receptor-specific ligand that can distinctly modulate target gene expression should be developed to overcome this issue. In this report, we showed that a pyrazolosteroid cortivazol (CVZ) does not induce either nuclear translocation or transactivation function of the mineralocorticoid receptor (MR), but does both of the glucocorticoid receptor (GR). Moreover, deletion analysis of the C-terminal end of the GR has revealed that CVZ interacts with the distinct portion of the ligand binding domain (LBD) and differentially modulates the ligand-dependent interaction between TIF2 and the LBD when compared with cortisol, dexamethasone, and aldosterone. It, thus, is indicated that CVZ may be not only a molecular probe for the analysis of the redundancy between the GR and MR in vivo but also a useful reagent to clarify structure-function relationship of the GR LBD.
J. Biol. Chem, 10.1074/jbc.M107946200
Submitted on August 17, 2001
Revised on November 27, 2001
Accepted on December 7, 2001
Distinct interaction of cortivazol with the ligand binding domain confers glucocorticoid receptor specificity
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Sola, J. D. Amaral, P. M. Borralho, R. M. Ramalho, R. E. Castro, M. M. Aranha, C. J. Steer, and C. M. P. Rodrigues Functional Modulation of Nuclear Steroid Receptors by Tauroursodeoxycholic Acid Reduces Amyloid {beta}-Peptide-Induced Apoptosis Mol. Endocrinol., October 1, 2006; 20(10): 2292 - 2303. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shimizu, R. Ouchida, N. Yoshikawa, T. Hisada, H. Watanabe, K. Okamoto, M. Kusuhara, H. Handa, C. Morimoto, and H. Tanaka HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b PNAS, June 14, 2005; 102(24): 8555 - 8560. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yoshikawa, K. Yamamoto, N. Shimizu, S. Yamada, C. Morimoto, and H. Tanaka The Distinct Agonistic Properties of the Phenylpyrazolosteroid Cortivazol Reveal Interdomain Communication within the Glucocorticoid Receptor Mol. Endocrinol., May 1, 2005; 19(5): 1110 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kodama, N. Shimizu, N. Yoshikawa, Y. Makino, R. Ouchida, K. Okamoto, T. Hisada, H. Nakamura, C. Morimoto, and H. Tanaka Role of the Glucocorticoid Receptor for Regulation of Hypoxia-dependent Gene Expression J. Biol. Chem., August 29, 2003; 278(35): 33384 - 33391. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |